<PAGE>
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q/A
QUARTERLY REPORT UNDER SECTION 13 OR 15 (D)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended October 31, 1995 Commission File Number
2-96510-N.Y.
DRUG GUILD DISTRIBUTORS, INC.
_______________________________________________________________
(Exact name of Registrant as specified in its Charter)
New Jersey 11-2269958
_______________________________________________________________
(State of other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
350 Meadowland Parkway, Secaucus, N.J. 07096
_______________________________________________________________
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code 201-348-3700
_______________________
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 of 15 (d) of the Securities Exchange Act of
1934 during the preceding 12 months ( or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. YES X NO______
Indicate the number of shares outstanding of each of the issuer's classes
of Common Stock as of the most recent practicable date:
As of October 31, 1995 there were outstanding 10,037,802 shares of the
Registrant's Common Stock, par value $1, and 30,102.58 shares of the
Registrant's Preferred Stock $100 par value.
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15 (d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be executed
on its behalf by the undersigned, thereunto duly authorized.
Date: December 15, 1995
DRUG GUILD DISTRIBUTORS, INC.
By /s/ Jay Reba
----------------------------------
Jay Reba,Vice President of Finance
(Duly authorized officer and
principal financial officer)
<PAGE>
EXHIBIT INDEX
Exhibit Description
------- -----------
27 Article 5 Financial Data Schedule
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
The schedule contains summary financial information extracted from [identify
specific financial statement[s]] and is qualified in its entirety by
reference to such financial statement[s].<F1>
</LEGEND>
<MULTIPLIER> 1
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUL-31-1996
<PERIOD-START> AUG-01-1995
<PERIOD-END> OCT-31-1995
<CASH> 7,009
<SECURITIES> 0
<RECEIVABLES> 69,598,766
<ALLOWANCES> (1,199,761)
<INVENTORY> 31,861,047
<CURRENT-ASSETS> 101,842,944
<PP&E> 13,643,158
<DEPRECIATION> 10,311,778
<TOTAL-ASSETS> 110,905,422
<CURRENT-LIABILITIES> 91,936,263
<BONDS> 697,574
<COMMON> 10,037,802
3,010,258
0
<OTHER-SE> 5,673,363
<TOTAL-LIABILITY-AND-EQUITY> 110,905,422
<SALES> 127,900,394
<TOTAL-REVENUES> 127,900,394
<CGS> 120,882,042
<TOTAL-COSTS> 120,882,042
<OTHER-EXPENSES> 5,817,903
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1,453,341
<INCOME-PRETAX> (252,892)
<INCOME-TAX> (101,000)
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 60,205
<CHANGES> 0
<NET-INCOME> 0
<EPS-PRIMARY> 0
<EPS-DILUTED> 0
</TABLE>
